Here are the 10-K annual reports from Novanta Inc. Tangible Equity Units (NOVTU) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow NOVTU and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NOVTU filings page.
Novanta Inc. reports on its 2025 performance as a global supplier of precision technologies for medical and advanced industrial OEMs. For the year ended December 31, 2025, Automation Enabling Technologies generated revenue of $500.8 million with a gross profit margin of 47.8% and operating profit of $114.5 million, while Medical Solutions delivered revenue of $479.8 million with a 41.6% gross profit margin and operating profit of $51.2 million.
Medical end markets represented about 53% of revenue and advanced industrial about 47%. Backlog was approximately $481.2 million as of December 31, 2025. The company strengthened its balance sheet by issuing 12,650,000 6.50% tangible equity units at $50.00 per unit, recording net proceeds of $613.1 million, and by entering a new $1.0 billion credit facility maturing in June 2030. Novanta also acquired Keonn Technologies for a total purchase price of $75.1 million, expanding its RFID capabilities within the Medical Solutions segment. As of February 16, 2026, Novanta had 35,683,769 common shares outstanding and non‑affiliate market value of $3.50 billion based on June 27, 2025 pricing.